Merck KGaA MRK-DE:XETRA

*Data is delayed | Exchange | EUR

Last | 5:38 PM CEST

133.50

+2.75 (+2.10%)

Volume

351,148

52 week range

100.70 - 133.75

Open131.70
Day High133.75
Day Low130.50
Prev Close130.75
52 Week High133.75
52 Week High Date06/03/26
52 Week Low100.70
52 Week Low Date03/23/26

Latest On Merck KGaA

European markets close higher, UK gilts volatile as pressure mounts on PM StarmerMay 13, 2026CNBC.com
European stocks close lower as Iran war continues to dominate sentimentMarch 5, 2026CNBC.com
Prices, pipelines and patent cliffs: Inside pharma's big resetFebruary 13, 2026CNBC.com
This is how exposed European Big Pharma is to the U.S.December 19, 2025CNBC.com
European markets lose earlier gains as U.S. shutdown endsNovember 13, 2025CNBC.com
Trump announces efforts to expand access to IVF drugsOctober 16, 2025CNBC.com
European pharma stocks close higher amid C-level shake-ups and listing chatterOctober 1, 2025CNBC.com
Why Trump's 100% drug tariffs could hit Asia and Europe very differentlySeptember 26, 2025CNBC.com
Engine Capital takes a stake in Avantor. Activist sees several ways to create valueAugust 16, 2025CNBC.com
European markets rise after Russia says Putin and Trump will meet in coming daysAugust 7, 2025CNBC.com

Key Stats

Market Cap58.043B
Shares Out434.78M
10 Day Average Volume0.37M
Dividend2.20
Dividend Yield1.65%
Beta0.83

Latest On Merck KGaA

European markets close higher, UK gilts volatile as pressure mounts on PM StarmerMay 13, 2026CNBC.com
European stocks close lower as Iran war continues to dominate sentimentMarch 5, 2026CNBC.com
Prices, pipelines and patent cliffs: Inside pharma's big resetFebruary 13, 2026CNBC.com
This is how exposed European Big Pharma is to the U.S.December 19, 2025CNBC.com
European markets lose earlier gains as U.S. shutdown endsNovember 13, 2025CNBC.com
Trump announces efforts to expand access to IVF drugsOctober 16, 2025CNBC.com
European pharma stocks close higher amid C-level shake-ups and listing chatterOctober 1, 2025CNBC.com
Why Trump's 100% drug tariffs could hit Asia and Europe very differentlySeptember 26, 2025CNBC.com
Engine Capital takes a stake in Avantor. Activist sees several ways to create valueAugust 16, 2025CNBC.com
European markets rise after Russia says Putin and Trump will meet in coming daysAugust 7, 2025CNBC.com

KEY STATS

Open131.70
Day High133.75
Day Low130.50
Prev Close130.75
52 Week High133.75
52 Week High Date06/03/26
52 Week Low100.70
52 Week Low Date03/23/26
Market Cap58.043B
Shares Out434.78M
10 Day Average Volume0.37M
Dividend2.20
Dividend Yield1.65%
Beta0.83

RATIOS/PROFITABILITY

EPS (TTM)5.83
P/E (TTM)22.92
Fwd P/E (NTM)-
EBITDA (TTM)6.068B
ROE (TTM)8.50%
Revenue (TTM)20.956B
Gross Margin (TTM)58.53%
Net Margin (TTM)12.14%
Debt To Equity (MRQ)40.38%

EVENTS

Earnings Date-
Ex Div Date04/27/2026
Div Amount2.20
Split Date-
Split Factor-

Content From Our Affiliates

J.P. Morgan Reaffirms Their Buy Rating on Merck KGaA (0O14)June 1, 2026TipRanks
Merck KGaA (0O14) Gets a Hold from Deutsche BankMay 27, 2026TipRanks
DZ BANK AG Sticks to Their Buy Rating for Merck KGaA (0O14)May 26, 2026TipRanks
J.P. Morgan Remains a Buy on Merck KGaA (0O14)May 26, 2026TipRanks
Merck KGaA (0O14) Receives a Hold from Deutsche BankMay 18, 2026TipRanks

Profile

Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business segment is operating in the therapeutic areas of oncology, neurology & immunology and fertility as well as cardiovascular, metabolic and endocrinological disorders. The Life Sciences segment is operating with its three business units such as, Science & Lab Solutions, Process Solutions and Life Science...

Helene Von Roeder

Chief Financial Officer, Member of the Executive Board

Address

Frankfurter Strasse 250

Darmstadt

64293

Germany

https://www.merckgroup.com/